Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study Oct 4, 2020 | Merkel Cell Carcinoma
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist. Apr 16, 2020 | Merkel Cell Carcinoma, Non-Small Cell Lung Cancer
